shelock
Infectious diseases caused by bacteria, viruses, fungi, and parasites cause millions of deaths worldwide every year.
Creative Biolabs offers in silico service for vaccine, which provides a way to predict and design new vaccine and vaccine components.
Non-Fucosylated Anti-Human G-Protein-coupled Receptor 49 (BNC101) Therapeutic Antibody, an ADCC-Enhanced Biobetter is available from creative biolabs.
Non-Fucosylated Anti-Human GPVI (9O12. 2) Therapeutic Antibody, an ADCC-Enhanced Biobetter is available from creative biolabs.
Non-Fucosylated Anti-Human Granulocyte colony-stimulating factor receptor (5D11) Therapeutic Antibody, an ADCC-Enhanced Biobetter is available from creative biolabs.
Non-Fucosylated Anti-Human Granulocyte Macrophage Colony Stimulating Factor (MORAb-022) Therapeutic Antibody, an ADCC-Enhanced Biobetter is available from creative biolabs.
S100A16 (S100 Calcium Binding Protein A16) is a Protein Coding gene. Diseases associated with S100A16 include Robinow Syndrome. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity.
Creative Biolabs can provide bispecific antibodies in various formats of appended IgGs.
Creative Biolabs provides GLP-compliant in vivo test services for anti-ROR1 CAR-T cell therapy in neuroblastoma, lung cancer, breast carcinoma, chronic lymphocytic leukemia and ovarian cancer.
Creative Biolabs provides GLP-compliant in vivo test services for anti-Tyrosinase (TYR) CAR-T cell therapy in melanoma.
Creative Biolabs offers multiple cancer vaccine formulation development services, including optimized formulation strategies, stability of formulations, etc.
Creative Biolabs offers advanced CAR-specific monoclonal antibody development services to detect CAR expression.
